European Lung Cancer Working Party Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Brussels Belgium (1989)

Organization Overview

First Clinical Trial
2000
NCT00658580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now